drugset / Trial / NCT03033264

Labor Induction With Dinoprostone in Oppose to Cervical Ripening Balloon as a Factor of BMI.

NCT03033264

Completed 164 enrolled Rambam Health Care Campus
RandomizedParallel-groupOpen-labelTreatment

Summary

Women with a BMI\>30 and women with a BMI\<30 will be divided in a randomized controlled manor to 4 groups depending on the mode of labor induction and BMI value: 1. Dinoprostone in women with a BMI\>30. 2. Dinoprostone in women with a BMI\<30. 3. Cervical ripening balloon in women with a BMI\>30. 4. Cervical ripening balloon in women with a BMI\<30. The subjects will be followed until labor, and information regarding the success of induction, mode of delivery and time of delivery will be collected from patients' electronic files.

Timeline

Start
2017-01-01
Primary completion
2020-07-31
Completion
2020-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 10 mg Intravenous

Indications

No indication recorded.